-
Most Recent
Search Results
240 results for frx
10 Best “Strong Buy” Stocks — TPL BITA QIHU and more
This week, these ten stocks, all currently earning A’s (“strong buy”) on Portfolio Grader, have the best year-to-date performance.
The Rules of Investing Just Changed — Are You Ready?
The way information moves, how investors react, and where the biggest opportunities appear have all changed. That’s why InvestorPlace Senior Analyst Louis Navellier is partnering…
This Biotech Bubble Is Bound to Burst
Biotech stocks have been hot thanks to a wave of M&A speculation. That wave, however, has run its course, putting these stocks and biotech ETFs…
Icahn Scores $535 Million — In One Week
Billionaire investor Carl Icahn made a mint on the Google-Motorola merger, but he also earned bank another way. See what he shorted.
Why This Company Could Be the “Forever Stock” of AI Healthcare
In 1979, General Electric introduced its famous tagline, “We bring good things to life.” It then brought its healthcare operations to life as GE HealthCare Technologies Inc.…
The 10 Best Stocks in the S&P 500 Through Q2
Energy and technology are well-represented in this list of the S&P 500’s best stocks through 2014’s midway point.
iBillionaire – What Do Hedge Fund Geniuses Like Right Now?
iBillionaire’s latest rebalancing reflects hedge funds’ interest in consumer discretionaries and tech right now.
Pharmaceutical Companies Hit New Highs, Solar Stocks New Lows
Solar stocks are among the investments hitting new 52 week lows today in the stock market as pharmaceutical companies hit new highs.
The CPI Takes Control – What It Means for the Fed’s Flight Plan
In today’s Market 360, we’ll break down what the latest CPI numbers reveal, why this means the Fed needs to cut key interest rates next…
Longtime Vanguard Health Care Manager Owens to Retire
Vanguard announced Wednesday that longtime Vanguard Health Care manager Edward Owens will be stepping down at the end of 2012.
2014’s 10 Best Stocks in the S&P 500
Don’t let the S&P 500’s weak 2014 performance fool you — the blue-chip index’s best stocks are a jumpy crowd that cruised 20%-50% in just…
Hertz (HTZ) Gives Carl Icahn 3 Board Seats to Avoid Proxy Battle
Hertz shares rise as the car rental company agrees to give activist investor Carl Icahn 3 board seats.
The Market Rally Resembles a Dog On a Bone
To this point in the year stocks, bonds, gold, oil and gas markets are working just fine, and my charts suggest more to come. Read…
41 S&P 500 Stocks Hit New Lows in Early Tuesday Trading
S&P 500 dips slightly Tuesday, with Urban Outfitters, Abercrombie & Fitch and Citigroup among losers by midday.
MRK: Merck Sells Consumer Business to Double Down on Blockbusters
Swinging for the fences, MRK sold one of the industry’s crown jewels in exchange for an opportunity to find new blockbuster drugs. It’s a risky…
Is Big Pharma Resistant to Antibiotics?
Less profitable drugs take a backseat despite health risks
How This 5-Stock AI Portfolio Outperformed Every Index
Today, AI predicts stock movements, spots market anomalies, and gives everyday investors access to the kind of insight once reserved for Wall Street’s elite. Our…
Actavis Prescribes Profits via M&A and Generic Drugs
This specialty pharmaceutical company is consolidating its way into becoming a post-Affordable Care Act powerhouse.
No Payday In Sight for Alzheimer’s Drug Stocks
At best, the drugs on the market are stopgap measures. They can’t cure the disease.
Is it Time to Follow Ichan Out of Amgen — and Other Biotechs?
Investor Carl Ichan recently dumped several biotechs. However, Amgen’s sales are strong, and with other positives, it’s possible he cut bait too soon.
Johnson & Johnson, Forest Labs Will Make You Sick
Johnson & Johnson beat expectations but its profits were down; Forest Labs missed and has a plunging profit forecast. Investors should be wary of both…
7 – 10 of 240 results
